Mogamulizumab for Sézary syndrome: long-term remission with associated autoimmune haemolytic anaemia
European Journal of Dermatology · 2024
DOI: 10.1684/ejd.2024.4744 ↗Kurz gefasst
Fallbericht in der Zeitschrift European Journal of Dermatology, 2024. Verfasst von Ana Maria Lé und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Unidade Local de Saúde de Santo António, Porto, Portugal. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Sezary Syndrome, Anemia, Hemolytic, Autoimmune, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Unidade Local de Saúde de Santo António, Porto, Portugal.
- Department of Clinical Hematology, Unidade Local de Saúde de Santo António, Porto, Portugal, Multidisciplinary Consultation for Cutaneous Lymphomas and Mastocytosis, Unidade Local de Saúde de Santo António, Porto, Portu…
- Laboratory of Cytometry, Department of Hematology, Unidade Local de Saúde de Santo António, Porto, Portugal.
- Department of Dermatology, Unidade Local de Saúde de Santo António, Porto, Portugal, Multidisciplinary Consultation for Cutaneous Lymphomas and Mastocytosis, Unidade Local de Saúde de Santo António, Porto, Portugal, Uni…
Zitieren
APA
Lé, A. M., Peixeiro, R., Lau, C., Teixeira, M. D. A., Cabral, R., & Fernandes, I. (2024). Mogamulizumab for Sézary syndrome: long-term remission with associated autoimmune haemolytic anaemia. European Journal of Dermatology. https://doi.org/10.1684/ejd.2024.4744
Vancouver
Lé AM, Peixeiro R, Lau C, Teixeira MDA, Cabral R, Fernandes I. Mogamulizumab for Sézary syndrome: long-term remission with associated autoimmune haemolytic anaemia. European Journal of Dermatology. 2024. doi:10.1684/ejd.2024.4744
BibTeX
@article{L2024,
author = {Lé, Ana Maria and Peixeiro, Rita and Lau, Catarina and Teixeira, Maria Dos Anjos and Cabral, Renata and Fernandes, Iolanda},
title = {Mogamulizumab for Sézary syndrome: long-term remission with associated autoimmune haemolytic anaemia},
journal = {European Journal of Dermatology},
year = {2024},
doi = {10.1684/ejd.2024.4744}
}
EUVIMED